u/SustainableStocks — reddlx

Moderna, Merck cancer combo cuts melanoma spread risk at five years

May 21 (Reuters) - Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another part of the body by 59% after five years of follow-up, data from ‌a mid-stage trial showed Thursday.

The study tested Moderna's experimental personalized cancer vaccine intismeran autogene, in combination with Merck's blockbuster immunotherapy Keytruda, in melanoma patients after surgery to assess whether the combination prevented their cancer from returning. The trial enrolled 157 patients from 2019 ⁠to 2021.

Link: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-merck-cancer-combo-cuts-melanoma-spread-risk-five-years-2026-05-21/

reddit.com

u/SustainableStocks — 1 day ago

▲ 19 r/ModernaStock

Bloomberg: Ebola vaccine may need many months of work before human trials:

I think even RFK Jr would be willing to throw a few hundred million to Moderna and Merck to push a potential Ebola vaccine into P1 trials. The argument that this Ebola outbreak is confined to Africa and that we shouldn’t care was illuminated by how global Covid 19 was in reach.

I unlocked the Bloomberg article link:

Other candidates in early stages of research are from the University of Oxford, US biotech Moderna Inc., Public Health Vaccines LLC and IAVI, she said.

https://www.bloomberg.com/news/articles/2026-05-19/ebola-vaccine-may-need-many-months-of-work-before-human-trials?accessToken=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzb3VyY2UiOiJTdWJzY3JpYmVyR2lmdGVkQXJ0aWNsZSIsImlhdCI6MTc3OTIxMzAxOSwiZXhwIjoxNzc5ODE3ODE5LCJhcnRpY2xlSWQiOiJURkFGUlRUOU5KTTcwMCIsImJjb25uZWN0SWQiOiJGRTk5QkYwREI0M0M0NEY1QUY5MTRFQzJGOTcyOEMzRCJ9.aky67hX\_7gGbgKY7ZrZbOmSnDFUzvlppA5\_spVQqfJI

u/SustainableStocks — 3 days ago

▲ 24 r/ModernaStock

Moderna has been working on an Ebola vaccine

Moderna is the only vaccine maker named in this article, as working on an Ebola vaccine with Oxford:

Oxford-Moderna partnership to develop the new ebola vaccine against this rare vatiant is the only option mentioned in this scientific article:

- This work (* Oxford-Moderna vaccine) must be brought forward.
- All known filovirus species shouldn’t wait for bureaucratic and regulatory slowness. Faster doesn’t mean cutting safety corners though.
- mRNA technology means that vaccines for filoviruses like Bundibugyo can be developed very quickly.

https://www.newscientist.com/article/2527072-the-ebola-emergency-shines-a-light-on-the-urgent-need-for-new-vaccines/

u/SustainableStocks — 3 days ago